| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |